Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last CNY16.80 CNY
Change Today -1.69 / -9.14%
Volume 9.5M
300026 On Other Exchanges
Symbol
Exchange
Shenzhen
As of 3:00 AM 09/1/15 All times are local (Market data is delayed by at least 15 minutes).

tianjin chase sun pharm-a (300026) Snapshot

Open
CNY17.99
Previous Close
CNY18.49
Day High
CNY18.00
Day Low
CNY16.64
52 Week High
06/17/15 - CNY32.80
52 Week Low
08/25/15 - CNY15.11
Market Cap
15.3B
Average Volume 10 Days
15.6M
EPS TTM
CNY0.54
Shares Outstanding
911.5M
EX-Date
05/26/15
P/E TM
31.2x
Dividend
CNY0.07
Dividend Yield
0.40%
Current Stock Chart for TIANJIN CHASE SUN PHARM-A (300026)

Related News

No related news articles were found.

tianjin chase sun pharm-a (300026) Related Businessweek News

No Related Businessweek News Found

tianjin chase sun pharm-a (300026) Details

Tianjin Chase Sun Pharmaceutical Co., Ltd is engaged in the research, development, manufacture, and distribution of various pharmaceutical products in China. The company offers XUEBIJING injection for the treatment of sepsis; TCM products; chemical synthetic drugs; biotechnology drugs; and medical devices. It is also involved in the research and development of various drugs in the therapeutic areas of pulmonary hypertension, leukemia, cardiovascular and cerebrovascular disease, arthritis, vascular disease, Ischemic stroke, HCV, psychosis, and chemotherapy, as well as anaesthesia drugs and Immunomodulator. Tianjin Chase Sun Pharmaceutical Co., Ltd was founded in 1996 and is based in Tianjin, China.

tianjin chase sun pharm-a (300026) Top Compensated Officers

No compensation data is available at this time for the top officers at this company.

Executives, Board Directors

tianjin chase sun pharm-a (300026) Key Developments

Tianjin Chase Sun Pharmaceutical Co., Ltd. to Report First Half, 2015 Results on Aug 18, 2015

Tianjin Chase Sun Pharmaceutical Co., Ltd. announced that they will report first half, 2015 results on Aug 18, 2015

Tianjin Chase Sun Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, Jul 14, 2015

Tianjin Chase Sun Pharmaceutical Co., Ltd., Special/Extraordinary Shareholders Meeting, Jul 14, 2015., at 14:00 China Standard Time. Agenda: To consider eligibility for assets purchase via share offering; to consider the transaction constitutes connected transaction; to consider transaction method, transaction counterpart and transaction object; to consider report on connected transaction regarding assets purchase via share offering and its summary; to sign conditional agreement on performance commitments and compensation of the assets purchase via share offering and cash payment with transaction parties; to consider audit report and evaluation report related to the major assets restructuring; to consider independence of evaluation institution, rationality of evaluation hypothesis, correlation between evaluation method and objective and fairness of evaluation pricing; and to consider statement on compliance and completeness of implementing the legal proceedings of the transaction and the effectiveness of the legal document submitted.

Tianjin Chase Sun Pharmaceutical Co., Ltd Proposes Cash Dividend for 2014

Tianjin Chase Sun Pharmaceutical Co., Ltd. proposed cash dividend/10 shares (tax included) of CNY 1.00 for 2014.

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
300026:CH CNY16.80 CNY -1.69

300026 Competitors

Market data is delayed at least 15 minutes.

Company Last Change
No competitor information is available for 300026.
View Industry Companies
 

Industry Analysis

300026

Industry Average

Valuation 300026 Industry Range
Price/Earnings 33.6x
Price/Sales 5.2x
Price/Book 4.6x
Price/Cash Flow 34.9x
TEV/Sales 4.9x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact TIANJIN CHASE SUN PHARM-A, please visit www.chasesun.cn. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.